(Q40683531)

22 September 2017

title

A new series of potent benzodiazepine gamma-secretase inhibitors (English)

1 reference

22 September 2017

Ian Churcher

1

1 reference

22 September 2017

Kate Ashton

2

1 reference

22 September 2017

John W Butcher

3

1 reference

22 September 2017

Earl E Clarke

4

1 reference

22 September 2017

Timothy Harrison

5

1 reference

22 September 2017

Huw D Lewis

6

1 reference

22 September 2017

Andrew P Owens

7

1 reference

22 September 2017

Martin R Teall

8

1 reference

22 September 2017

Susie Williams

9

1 reference

22 September 2017

Jonathan D J Wrigley

10

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

22 September 2017

published in

1 reference

22 September 2017

volume

13

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

179-183

1 reference

Factors influencing the processing and function of the amyloid beta precursor protein--a potential therapeutic target in Alzheimer's disease?

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

Beta-amyloid therapies in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

Intramembrane proteolysis by presenilins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

Presenilin and gamma-secretase: structure meets function

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

Translating cell biology into therapeutic advances in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

Secretase targets for Alzheimer's disease: identification and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

The search for gamma-secretase and development of inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

Quantitation of amyloid-beta peptides in biological milieu using a novel homogeneous time-resolved fluorescence (HTRF) assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

Asymmetric alkylation reactions of chiral imide enolates. A practical approach to the enantioselective synthesis of .alpha.-substituted carboxylic acid derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

Crystallization-induced asymmetric transformation: stereospecific synthesis of a potent peripheral CCK antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900909-5

7 January 2021

10.1016/S0960-894X(02)00909-5

Identifiers

DOI

1 reference

22 September 2017

1 reference